Una candidatura completa en un minuto
Currículum y carta de presentación personalizados, listos para enviar.
Orion Pharma is seeking a senior scientific leader to head the Toxicology and Integrated DMPK & Safety organization within its Research & Development division. The role involves strategic direction for preclinical DMPK, safety, and in vivo facilities, driving robust safety strategies across all drug development stages.
The position offers relocation support and can be based in Cambridge, UK or Espoo/Turku, Finland.
Orion Corporation (Orion Pharma) is a well‑established, financially stable pharmaceutical company operating in more than 35 countries, including our recently established R&D hubs in Cambridge, USA and Cambridge, UK. We are now seeking an experienced scientific leader to lead the Toxicology and Integrated DMPK & Safety organization in Orion Pharma's Research & Development organization.
In this senior leadership role, you will provide strategic direction for Orion Pharma’s Integrated DMPK & Safety department responsible for preclinical DMKP and safety and toxicology functions including in vivo facilities. You will foster a culture of innovation, collaboration, and scientific excellence while driving robust nonclinical DMPK & safety strategies that support all stages of drug development. Your deep expertise across key safety disciplines—such as general toxicology, safety pharmacology, genotoxicity, reproductive toxicology, and carcinogenicity—will ensure high‑quality decision‑making that aligns with Orion’s scientific and business objectives.
This role is a member of RD leadership team and reports to the Executive Vice President of Research & Development organization. As a member of RD LT, broad and deep scientific and strategic contribution to the whole R&D is an important part of the role.
The position can be based in Cambridge, UK or in Espoo or Turku, Finland. Relocation support is available.
At Orion Pharma, we provide a dynamic and innovative research environment where your expertise will directly shape the future of our preclinical safety & toxicology function. Our culture is built on mutual respect, scientific excellence, and continuous learning—supporting a sense of purpose, belonging, and shared achievement. With collaboration spanning global teams, you will have the space to influence meaningful scientific and organisational impact.
We offer competitive compensation and a comprehensive benefits package designed to support your professional and personal wellbeing.
Learn more about our values and what it’s like to work at Orion Pharma:
https://www.orion.fi/en/careers/orion-as-an-employer/
Flexible hybrid work is available in line with Orion’s guidelines.
If this role aligns with your interests and aspirations, we encourage you to apply no later than November 30th, 2026. This recruitment process is conducted in collaboration with an external recruitment partner, and by submitting your application to Orion Pharma, you consent to your personal data being processed by the appointed recruitment agency for the purposes of this hiring process. Please note that only candidates whose background and experience are considered suitable will be contacted.
Orion’s pharmaceutical innovations are created within its R&D organization. We employ top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in Cambridge, USA. Orion R&D and the Innovative Medicines business division are dedicated to becoming a global player in oncology and pain therapy areas.
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well‑being for over a hundred years.
We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.
Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.
We offer careers with a clear purpose: empowering people to live their lives to the fullest.